| Sonia Yousuf, MD | |
|
1807 W Slaughter Ln, Suite 490, Austin, TX 78748-6230 | |
| (512) 282-8937 | |
| (512) 406-7351 |
| Full Name | Sonia Yousuf |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 25 Years |
| Location | 1807 W Slaughter Ln, Austin, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194851394 | NPI | - | NPPES |
| 350883001 | Medicaid | TX | |
| 350883002 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 4301089195 (Michigan) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | Q0850 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Austin Regional Clinic Pa | 3072507789 | 349 |
News Archive
Now, an intriguing preprint research paper on the bioRxiv server reports the identification of an enzyme called chitinase 3-like-1 (CHI3L1) that mediates this age-dependent impact of the virus and could serve as a powerful therapeutic approach in mitigating the severity of COVID-19 in this high-risk group.
Daxor Corporation, a medical instrumentation and biotechnology company, today announced that The Board of Directors has voted to declare a special year-end dividend of $1.00 per share. The dividend will be paid to shareholders of record as of December 10, 2009. The dividend will be paid on Thursday, December 24, 2009.
A study that appears in the May edition of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, shows that as many as 47 percent of patients receiving glaucoma therapy do not comply with their doctor's prescribed medicine regimen. This is in startling contrast to the 90 percent of doctors who believe that their patients are following the prescribed treatment.
The Coalition for Pulmonary Fibrosis (CPF) is urging the more than 128,000 people known to suffer from the deadly lung disease, pulmonary fibrosis (PF), to consider clinical trials, including two new ones funded by the National Institutes of Health (NIH). Clinical trials of potential drug therapies are critical to the discovery of treatments for any disease and for a disease like PF that claims as many lives each year as breast cancer with virtually no survivors, they are the likely path to answers and saved lives.
› Verified 3 days ago
| Entity Name | Austin Regional Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821157579 PECOS PAC ID: 3072507789 Enrollment ID: O20040414000198 |
News Archive
Now, an intriguing preprint research paper on the bioRxiv server reports the identification of an enzyme called chitinase 3-like-1 (CHI3L1) that mediates this age-dependent impact of the virus and could serve as a powerful therapeutic approach in mitigating the severity of COVID-19 in this high-risk group.
Daxor Corporation, a medical instrumentation and biotechnology company, today announced that The Board of Directors has voted to declare a special year-end dividend of $1.00 per share. The dividend will be paid to shareholders of record as of December 10, 2009. The dividend will be paid on Thursday, December 24, 2009.
A study that appears in the May edition of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, shows that as many as 47 percent of patients receiving glaucoma therapy do not comply with their doctor's prescribed medicine regimen. This is in startling contrast to the 90 percent of doctors who believe that their patients are following the prescribed treatment.
The Coalition for Pulmonary Fibrosis (CPF) is urging the more than 128,000 people known to suffer from the deadly lung disease, pulmonary fibrosis (PF), to consider clinical trials, including two new ones funded by the National Institutes of Health (NIH). Clinical trials of potential drug therapies are critical to the discovery of treatments for any disease and for a disease like PF that claims as many lives each year as breast cancer with virtually no survivors, they are the likely path to answers and saved lives.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sonia Yousuf, MD 4515 Seton Center Pkwy, Suite 215-credentialing, Austin, TX 78759-5290 Ph: () - | Sonia Yousuf, MD 1807 W Slaughter Ln, Suite 490, Austin, TX 78748-6230 Ph: (512) 282-8937 |
News Archive
Now, an intriguing preprint research paper on the bioRxiv server reports the identification of an enzyme called chitinase 3-like-1 (CHI3L1) that mediates this age-dependent impact of the virus and could serve as a powerful therapeutic approach in mitigating the severity of COVID-19 in this high-risk group.
Daxor Corporation, a medical instrumentation and biotechnology company, today announced that The Board of Directors has voted to declare a special year-end dividend of $1.00 per share. The dividend will be paid to shareholders of record as of December 10, 2009. The dividend will be paid on Thursday, December 24, 2009.
A study that appears in the May edition of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, shows that as many as 47 percent of patients receiving glaucoma therapy do not comply with their doctor's prescribed medicine regimen. This is in startling contrast to the 90 percent of doctors who believe that their patients are following the prescribed treatment.
The Coalition for Pulmonary Fibrosis (CPF) is urging the more than 128,000 people known to suffer from the deadly lung disease, pulmonary fibrosis (PF), to consider clinical trials, including two new ones funded by the National Institutes of Health (NIH). Clinical trials of potential drug therapies are critical to the discovery of treatments for any disease and for a disease like PF that claims as many lives each year as breast cancer with virtually no survivors, they are the likely path to answers and saved lives.
› Verified 3 days ago
Dr. Tatiana B. Jacobson, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5656 Bee Caves Rd. Bldg C Ste. 102, Austin, TX 78746 Phone: 512-323-5465 Fax: 512-327-1390 | |
Preeti Venkatraman, M.B.B.S. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 601 E 15th St, Austin, TX 78701 Phone: 512-324-7000 | |
Pritesh Harish Gandhi, M.D., M.P.H. Rheumatology Medicare: Medicare Enrolled Practice Location: 1101 Camino La Costa, Austin, TX 78752 Phone: 512-684-1832 | |
Dr. Joshua Lane Davis, D.O. Rheumatology Medicare: Medicare Enrolled Practice Location: 1004 W 32nd St Unit 300, Austin, TX 78705 Phone: 512-324-3440 | |
Dr. Analicia Alvarado, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1500 Red River St, Austin, TX 78701 Phone: 512-324-7000 | |
Dr. Grace Marie Grant-jennings, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 7000 North Mopac, Suite # 420, Austin, TX 78731 Phone: 512-482-0045 Fax: 512-476-9892 | |
Dr. Debra Ann Patt, MD, MPH Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6204 Balcones Dr, Austin, TX 78731 Phone: 512-427-9400 Fax: 512-342-2723 |